Works matching AU Enokida, Hideki


Results: 95
    1

    Epigenetics in bladder cancer.

    Published in:
    International Journal of Clinical Oncology, 2008, v. 13, n. 4, p. 298, doi. 10.1007/s10147-008-0811-1
    By:
    • Enokida, Hideki;
    • Nakagawa, Masayuki
    Publication type:
    Article
    2

    Real-world treatment outcomes of patients with penile cancer in the Kyushu–Okinawa area of Japan in the pre-guideline era.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 837, doi. 10.1093/jjco/hyad053
    By:
    • Yamaguchi, Takahiro;
    • Goya, Masato;
    • Higashijima, Katsuyoshi;
    • Tobu, Shohei;
    • Sato, Ryuta;
    • Tatarano, Shuichi;
    • Mukai, Shoichiro;
    • Uemura, Kei-ichiro;
    • Tatsugami, Katsunori;
    • Tsubouchi, Kazuna;
    • Shida, Yohei;
    • Ishii, Tatsu;
    • Sakai, Hideki;
    • Matsuoka, Hirofumi;
    • Haga, Nobuhiro;
    • Eto, Masatoshi;
    • Igawa, Tsukasa;
    • Kamoto, Toshiyuki;
    • Enokida, Hideki;
    • Shin, Toshitaka
    Publication type:
    Article
    3

    Erratum to: Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1484, doi. 10.1093/jjco/hyaa227
    By:
    • Enokida, Hideki;
    • Yamada, Yasutoshi;
    • Tatarano, Shuichi;
    • Yoshino, Hirofumi;
    • Yonemori, Masaya;
    • Sakaguchi, Takashi;
    • Nishimura, Hiroaki;
    • Eura, Rumiko;
    • Nakagawa, Masayuki
    Publication type:
    Article
    4

    Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 1, p. 66, doi. 10.1093/jjco/hyz138
    By:
    • Enokida, Hideki;
    • Yamada, Yasutoshi;
    • Tatarano, Shuichi;
    • Yoshino, Hirofumi;
    • Yonemori, Masaya;
    • Sakaguchi, Takashi;
    • Nishimura, Hiroaki;
    • Eura, Rumiko;
    • Nakagawa, Masayuki
    Publication type:
    Article
    5

    Laparoscopic Surgery for Pheochromocytoma in Hemodialysis Patients.

    Published in:
    International Journal of Nephrology, 2022, p. 1, doi. 10.1155/2022/3060647
    By:
    • Tatarano, Shuichi;
    • Mitsuke, Akihiko;
    • Sakaguchi, Takashi;
    • Matsushita, Ryosuke;
    • Inoguchi, Satoru;
    • Yoshino, Hirofumi;
    • Nishimura, Hiroaki;
    • Yamada, Yasutoshi;
    • Enokida, Hideki
    Publication type:
    Article
    6

    Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1776, doi. 10.3390/ijms26041776
    By:
    • Saito, Saeki;
    • Yoshino, Hirofumi;
    • Yokoyama, Seiya;
    • Tominaga, Mitsuhiko;
    • Li, Gang;
    • Arima, Junya;
    • Kawahara, Ichiro;
    • Fukuda, Ikumi;
    • Mitsuke, Akihiko;
    • Sakaguchi, Takashi;
    • Inoguchi, Satoru;
    • Matsushita, Ryosuke;
    • Yamada, Yasutoshi;
    • Tatarano, Shuichi;
    • Tanimoto, Akihide;
    • Enokida, Hideki
    Publication type:
    Article
    7
    8
    9

    Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer.

    Published in:
    PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058929
    By:
    • Chiyomaru, Takeshi;
    • Yamamura, Soichiro;
    • Fukuhara, Shinichiro;
    • Hidaka, Hideo;
    • Majid, Shahana;
    • Saini, Sharanjot;
    • Arora, Sumit;
    • Deng, Guoren;
    • Shahryari, Varahram;
    • Chang, Inik;
    • Tanaka, Yuichiro;
    • Tabatabai, Z. Laura;
    • Enokida, Hideki;
    • Seki, Naohiko;
    • Nakagawa, Masayuki;
    • Dahiya, Rajvir
    Publication type:
    Article
    10

    Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151.

    Published in:
    PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043812
    By:
    • Chiyomaru, Takeshi;
    • Yamamura, Soichiro;
    • Zaman, Mohd Saif;
    • Majid, Shahana;
    • Deng, Guoren;
    • Shahryari, Varahram;
    • Saini, Sharanjot;
    • Hirata, Hiroshi;
    • Ueno, Koji;
    • Chang, Inik;
    • Tanaka, Yuichiro;
    • Tabatabai, Z. Laura;
    • Enokida, Hideki;
    • Nakagawa, Masayuki;
    • Dahiya, Rajvir;
    • Sarkar, Fazlul H.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    The role of microRNAs in bladder cancer.

    Published in:
    Investigative & Clinical Urology, 2016, v. 57, p. S60, doi. 10.4111/icu.2016.57.S1.S60
    By:
    • Hideki Enokida;
    • Hirofumi Yoshino;
    • Ryosuke Matsushita;
    • Masayuki Nakagawa
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Validation of non‐muscle‐invasive bladder cancer risk stratification updated in the 2021 European Association of Urology guidelines.

    Published in:
    BJUI Compass, 2024, v. 5, n. 2, p. 269, doi. 10.1002/bco2.305
    By:
    • Miyake, Makito;
    • Kitamura, Hiroshi;
    • Nishimura, Nobutaka;
    • Miyamoto, Tatsuki;
    • Nakahama, Tomonori;
    • Fujii, Tomomi;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Yonemori, Masaya;
    • Enokida, Hideki;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Matsui, Yoshiyuki;
    • Nishiyama, Naotaka;
    • Nishiyama, Hiroyuki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    38
    39

    Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa.

    Published in:
    Cancers, 2024, v. 16, n. 3, p. 508, doi. 10.3390/cancers16030508
    By:
    • Mita, Koji;
    • Izumi, Kouji;
    • Goriki, Akihiro;
    • Tasaka, Ryo;
    • Hatayama, Tomoya;
    • Shima, Takashi;
    • Kato, Yuki;
    • Kamiyama, Manabu;
    • Inoue, Shogo;
    • Tanaka, Nobumichi;
    • Hoshi, Seiji;
    • Okamura, Takehiko;
    • Yoshio, Yuko;
    • Enokida, Hideki;
    • Chikazawa, Ippei;
    • Kawai, Noriyasu;
    • Hashimoto, Kohei;
    • Fukagai, Takashi;
    • Shigehara, Kazuyoshi;
    • Takahara, Shizuko
    Publication type:
    Article
    40
    41
    42

    A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 7, p. 1364, doi. 10.1007/s10147-020-01654-5
    By:
    • Miyake, Makito;
    • Matsuyama, Hideyasu;
    • Teramukai, Satoshi;
    • Kinoshita, Fumie;
    • Yokota, Isao;
    • Matsumoto, Hiroaki;
    • Shimada, Keiji;
    • Kinjyo, Mitsuru;
    • Shimokama, Tatsuro;
    • Okumura, Koji;
    • Yomenori, Masaya;
    • Enokida, Hideki;
    • Nakagawa, Masayuki;
    • Nakai, Yasushi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    43

    Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 165, doi. 10.1007/s10147-019-01545-4
    By:
    • Nishiyama, Hiroyuki;
    • Yamamoto, Yoshiaki;
    • Sassa, Naoto;
    • Nishimura, Kazuo;
    • Fujimoto, Kiyohide;
    • Fukasawa, Satoshi;
    • Yokoyama, Minato;
    • Enokida, Hideki;
    • Takahashi, Kenichi;
    • Tanaka, Yoshinobu;
    • Imai, Kentaro;
    • Shimamoto, Takashi;
    • Perini, Rodolfo;
    • Frenkl, Tara;
    • Bajorin, Dean;
    • Bellmunt, Joaquim
    Publication type:
    Article
    44

    Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.

    Published in:
    PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0287059
    By:
    • Mitsuke, Akihiko;
    • Ohbo, Takahiko;
    • Arima, Junya;
    • Osako, Yoichi;
    • Sakaguchi, Takashi;
    • Matsushita, Ryosuke;
    • Yoshino, Hirofumi;
    • Tatarano, Shuichi;
    • Yamada, Yasutoshi;
    • Sasaki, Hajime;
    • Tanabe, Tatsu;
    • Fukuzawa, Nobuyuki;
    • Tanaka, Hiroshi;
    • Nishio, Yoshihiko;
    • Hideki, Enokida;
    • Harada, Hiroshi
    Publication type:
    Article
    45
    46
    47
    48
    49

    Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification.

    Published in:
    BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-13109-5
    By:
    • Fukumoto, Wataru;
    • Okamura, Shunsuke;
    • Tamai, Motoki;
    • Arima, Junya;
    • Kawahara, Ichiro;
    • Fukuda, Ikumi;
    • Mitsuke, Akihiko;
    • Sakaguchi, Takashi;
    • Sugita, Satoshi;
    • Matsushita, Ryosuke;
    • Tatarano, Shuichi;
    • Yamada, Yasutoshi;
    • Nakagawa, Masayuki;
    • Enokida, Hideki;
    • Yoshino, Hirofumi
    Publication type:
    Article
    50

    Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial.

    Published in:
    2017
    By:
    • Kouji Izumi;
    • Atsushi Mizokami;
    • Mikio Namiki;
    • Shogo Inoue;
    • Nobumichi Tanaka;
    • Yuko Yoshio;
    • Kei Ishibashi;
    • Manabu Kamiyama;
    • Noriyasu Kawai;
    • Hideki Enokida;
    • Takashi Shima;
    • Shizuko Takahara;
    • Izumi, Kouji;
    • Mizokami, Atsushi;
    • Namiki, Mikio;
    • Inoue, Shogo;
    • Tanaka, Nobumichi;
    • Yoshio, Yuko;
    • Ishibashi, Kei;
    • Kamiyama, Manabu
    Publication type:
    journal article